Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

M Nagai, DB Re, T Nagata, A Chalazonitis… - Nature …, 2007 - nature.com
M Nagai, DB Re, T Nagata, A Chalazonitis, TM Jessell, H Wichterle, S Przedborski
Nature neuroscience, 2007nature.com
Mutations in superoxide dismutase-1 (SOD1) cause a form of the fatal paralytic disorder
amyotrophic lateral sclerosis (ALS), presumably by a combination of cell-autonomous and
non–cell-autonomous processes. Here, we show that expression of mutated human SOD1
in primary mouse spinal motor neurons does not provoke motor neuron degeneration.
Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic
mouse stem cell–derived motor neurons. This is triggered by soluble toxic factor (s) through …
Abstract
Mutations in superoxide dismutase-1 (SOD1) cause a form of the fatal paralytic disorder amyotrophic lateral sclerosis (ALS), presumably by a combination of cell-autonomous and non–cell-autonomous processes. Here, we show that expression of mutated human SOD1 in primary mouse spinal motor neurons does not provoke motor neuron degeneration. Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cell–derived motor neurons. This is triggered by soluble toxic factor(s) through a Bax-dependent mechanism. However, mutant astrocytes do not cause the death of spinal GABAergic or dorsal root ganglion neurons or of embryonic stem cell–derived interneurons. In contrast to astrocytes, fibroblasts, microglia, cortical neurons and myocytes expressing mutated SOD1 do not cause overt neurotoxicity. These findings indicate that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS. Identification of the astrocyte-derived soluble factor(s) may have far-reaching implications for ALS from both a pathogenic and therapeutic standpoint.
nature.com